Eli Lilly and Co (LLY)
749.91
-3.50
(-0.46%)
USD |
NYSE |
Nov 21, 16:00
749.01
-0.90
(-0.12%)
After-Hours: 16:23
Eli Lilly Market Cap: 711.90B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 715.22B |
| November 19, 2024 | 692.74B |
| November 18, 2024 | 690.34B |
| November 15, 2024 | 708.38B |
| November 14, 2024 | 746.38B |
| November 13, 2024 | 770.66B |
| November 12, 2024 | 777.36B |
| November 11, 2024 | 790.25B |
| November 08, 2024 | 789.39B |
| November 07, 2024 | 757.03B |
| November 06, 2024 | 737.03B |
| November 05, 2024 | 765.21B |
| November 04, 2024 | 765.28B |
| November 01, 2024 | 777.42B |
| October 31, 2024 | 787.69B |
| October 30, 2024 | 803.91B |
| October 29, 2024 | 857.78B |
| October 28, 2024 | 850.20B |
| October 25, 2024 | 847.45B |
| October 24, 2024 | 802.05B |
| October 23, 2024 | 812.79B |
| October 22, 2024 | 818.10B |
| October 21, 2024 | 815.38B |
| October 18, 2024 | 826.04B |
| October 17, 2024 | 825.27B |
| Date | Value |
|---|---|
| October 16, 2024 | 824.64B |
| October 15, 2024 | 821.85B |
| October 14, 2024 | 836.42B |
| October 11, 2024 | 838.71B |
| October 10, 2024 | 819.48B |
| October 09, 2024 | 827.63B |
| October 08, 2024 | 822.21B |
| October 07, 2024 | 808.43B |
| October 04, 2024 | 798.31B |
| October 03, 2024 | 796.86B |
| October 02, 2024 | 801.83B |
| October 01, 2024 | 795.90B |
| September 30, 2024 | 797.21B |
| September 27, 2024 | 790.38B |
| September 26, 2024 | 818.78B |
| September 25, 2024 | 832.50B |
| September 24, 2024 | 832.38B |
| September 23, 2024 | 827.06B |
| September 20, 2024 | 829.73B |
| September 19, 2024 | 823.93B |
| September 18, 2024 | 814.86B |
| September 17, 2024 | 815.95B |
| September 16, 2024 | 831.58B |
| September 13, 2024 | 831.73B |
| September 12, 2024 | 841.92B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
110.18B
Minimum
Nov 21 2019
864.43B
Maximum
Aug 30 2024
352.16B
Average
286.16B
Median
Aug 11 2022
Market Cap Benchmarks
| Amgen Inc | 155.82B |
| Biogen Inc | 23.00B |
| Johnson & Johnson | 374.39B |
| Viking Therapeutics Inc | 5.757B |
| Moderna Inc | 14.72B |
Market Cap Related Metrics
| PE Ratio | 81.07 |
| PS Ratio | 16.59 |
| PEG Ratio | 1.147 |
| Price to Book Value | 49.99 |
| Price | 749.91 |
| Earnings Yield | 1.23% |
| PEGY Ratio | 1.136 |
| Operating PE Ratio | 44.82 |
| Normalized PE Ratio | 60.10 |